null

Anti-LEPR (Mibavademab biosimilar) mAb (HDBS0439)

SKU:
HDBS0439
Antibody Type:
Biosimilar Reference Antibody
Applications:
IHC
FC
Drug Development
Pharmacokinetics
Disease Area:
Cancer
Size:
100 μg
Target:
LEPR
Isotype:
IgG4
Host Species:
Homo sapiens Humanized
Reactivity:
Human
  • Anti-LEPR (Mibavademab biosimilar) mAb (HDBS0439)
  • Anti-LEPR (Mibavademab biosimilar) mAb (HDBS0439)
$515

Description

system_update_altDatasheetsystem_update_altMSDS
Product Name:Anti-LEPR (Mibavademab biosimilar) mAb
SKU:HDBS0439
Size:100 μg
Target:LEPR
Common Name:REGN4461
Isotype:IgG4
Host Species:Homo sapiens Humanized
Reactivity:Human
Synonyms:LEP-R; CD295; DB; OBR
Applications:ELISA  Flow Cyt
Recommended Dilutions:ELISA 1:5000-10000, Flow Cyt 1:100
Conjugate:Unconjugated

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Uniprot:P48357
Formulation & Reconstitution:Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution.
Usage:Research use only
Storage & Shipping:Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.

Related Products